|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Income (loss) from continuing operations, net of tax | |||||
| Income from discontinued operations, net of tax | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation and amortization, net | |||||
| Deferred tax benefit | |||||
| Net securities losses | |||||
| Loss on sales of loans | |||||
| Gain on sale of discontinued operations | |||||
| Stock-based compensation expense | |||||
| Other fair value adjustments | |||||
| Loans held for sale: | |||||
| Originations and purchases | |||||
| Proceeds from sales and paydowns | |||||
| Changes in operating assets and liabilities: | |||||
| Changes in interest receivable | |||||
| Changes in other assets | |||||
| Changes in interest payable | |||||
| Changes in other liabilities | |||||
| Net change from discontinued operations | |||||
| Net cash from operating activities | |||||
| Investing activities: | |||||
| Securities available for sale: | |||||
| Purchases | |||||
| Proceeds from paydowns and maturities | |||||
| Proceeds from sales | |||||
| Proceeds from sales of securities related to the Transaction | |||||
| Net changes in loans originated as held for investment | |||||
| Principal recoveries of loans previously charged off | |||||
| Changes in premises and equipment | |||||
| Net cash received (paid) in acquisitions | |||||
| Proceeds from divestiture of business | |||||
| Net cash used in other investing activities | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Changes in deposits | |||||
| Issuance of securitized debt obligations | |||||
| Maturities and paydowns of securitized debt obligations | |||||
| Issuance of senior and subordinated notes and long-term FHLB advances | |||||
| Maturities and paydowns of senior and subordinated notes | |||||
| Changes in other borrowings | |||||
| Common stock: | |||||
| Net proceeds from issuances | |||||
| Dividends paid | |||||
| Preferred stock: | |||||
| Net proceeds from issuances | |||||
| Dividends paid | |||||
| Redemptions | |||||
| Purchases of treasury stock | |||||
| Proceeds from share-based payment activities | |||||
| Net cash from (used in) financing activities | |||||
| Changes in cash, cash equivalents and restricted cash for securitization investors | |||||
| Cash, cash equivalents and restricted cash for securitization investors, beginning of the period | |||||
| Cash, cash equivalents and restricted cash for securitization investors, end of the period | |||||
| Supplemental cash flow information: | |||||
| Net transfers from loans held for investment to loans held for sale | |||||
| Interest paid | |||||
| U.S. federal | |||||
| Domestic state and local: | |||||
| CALIFORNIA | |||||
| NEW YORK | |||||
| State and Local Tax Jurisdiction, Other | |||||
| Total domestic state and local: | |||||
| Foreign | |||||
| Income taxes paid | |||||
| Purchased tax credits | |||||
| Reissuance of treasury stock, issuance of preferred stock and stock-based compensation awards related to the Transaction | |||||
Loading...